Effects of myocardial protection on hypertrophic rabbit hearts: Structural and ultra structural analysis;Efeitos das cardioplegias sangüínea e cristalóide no miocárdio hipertrófico de coelho: Avaliação estrutural e ultra-estrutural

Brazilian Journal of Cardiovascular Surgery

Volumn 22, Issue 1, 2007, Pages 24-32

  Cressoni, Elthon Silveira ^a,c   Avanci, Luiz Ernesto ^c   Braile, Domingo Marcolino ^b   Lima Oliveira, Ana Paula Marques ^c   Taboga, Sebastião Roberto ^c   Martins, Antonio Sérgio ^c   Oyama, Rosa Sayoko Kawasaki ^c   De Oliveira, Marcos Aurélio Barbosa ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Medical School in Sao Jose do Rio Preto FAMERP   (Brazil)

^c NONE

Author keywords

Cardiac surgical procedures; Cardioplegic solutions, pharmacology; Hypertrophy

Indexed keywords

EID: 34447136091     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/s0102-76382007000100008     Document Type: Article

References (28)

1. Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz. 2006;31(4):305-16.
2. Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients. Ital Heart J. 2004;5(7):505-10.
3. Rosei EA, Muiesan ML. Early target organ damage and its reversibility: the heart. J Hypertens Suppl. 2005;23(1):S27-33.
4. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl. 2005;23(1):S27-33.
5. Ascione R, Caputo M, Gomes WJ, Lotto AA, Bryan AJ, Angelini GD, et al. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. Eur J Cardiothorac Surg. 2002;21(3):440-6.
6. Khuri SF, Warner KG, Josa M, Butler M, Hayes A, Hanson R, et al. The superiority of continuous cold blood cardioplegia in the metabolic protection of the hypertrophied human heart. J Thorac Cardiovasc Surg. 1988;95(3):422-54.
7. Melrose DG, Dreyer B, Bentall HH, Baker JB. Elective cardiac arrest. Lancet. 1955;269(6879):21-2.
8. Shumway NE, Lower RR, Stofer RC. Selective hypothermia of the heart in anoxic cardiac arrest. Surg Gynecol Obstet. 1959;109:750-4.
9. Évora PRB, Pearson PJ, Discigil B, Oeltjen M, Schaff HV. Efeito protetor da criocardioplegia cristalóide na isquemia global e reperfusão durante circulação extracorpórea: um mecanismo dependente do endotélio? Rev Bras Cir Cardiovasc. 1997;12(1):68-76.
10. Marban E, Koretsune Y, Correntti M, Chacko VP, Kusuoka H. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation. 1989;80(6 Suppl):IV17-22.
11. Braile DM, Ardito RV, Thevenard GHP, Ramin SL, Silva EM. Cardioplegia sangüínea normotérmica na revascularização cirúrgica do miocárdio. Rev Soc Cardiol Estado de São Paulo 1991;1(1):26-37.
12. Souza MHL, Elias DO. Fundamentos da circulação extracorpórea. vol I. Rio de Janeiro:Centro Editorial Alfa Rio;1995. p.255-73.
13. Lima-Oliveira APM, Azeredo-Oliveira MTV, Taboga SR, Godoy MF, Braile DM. Cardioplegia using low volumic cardioplegic agents: morphological study in isolated rabbit hearts. Braz J Cardiovasc Surg. 2003;18(3):227-34.
14. Martins AS, Matsubara BB, Braile DM, Gomes OM. Proteção miocárdica e função ventricular. Botucatu: Cultura. Acadêmica Editora;2004. p.262.
15. Oliveira MAB, Godoy MF, Braile DM, Lima-Oliveira APM. Polarizing cardioplegic solution: state of the art. Braz J Cardiovasc Surg. 2005;20(1):69-74.
16. Martins AS, Aguilera NW, Matsubara BB, Bregagnollo EA. Experimental myocardial hypertrophy induced by a minimally invasive ascending aorta coarctation. Braz J Med Biol Res. 2001;34(3):413-5.
17. Godoy MF, Braile DM, Purini Neto J. A troponina como marcador de injúria celular miocárdica. Arq Bras Cardiol. 1998;71(4):629-33.
18. a ed. Rio de Janeiro:Guanabara Koogan;2000. p.159-78.
19. Constantidines P. General pathobiology. Norwich:Appleton & Lange;1993. p.117-31.
20. Ascione R, Caputo M, Gomes WJ, Lotto AA, Bryan AJ, Angelini GD, et al. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. Eur J Cardiothorac Surg. 2002;21(3):440-6.
21. aed. rev ampl. São José do Rio Preto;1997. 53p. Apostila.
22. Constantidines P. General pathobiology. Norwich:Appleton & Lange;1994.p.1-58.
23. Shimada Y. Does angiotensin converting enzyme inhibitor protect the heart in cardiac surgery? From laboratory to operating room: clinical application of experimental study. Curr Pharm Des. 2006;12(4):517-26.
24. Lima-Oliveira APM. Fenótipos nucleares decorrentes da cardioplegia com e sem proteção: estudo experimental em coelhos [Tese de Doutorado]. São José do Rio Preto:Instituto de Biociências, Letras e Ciências Exatas da Universidade Paulista (IBILCE-UNESP);2003. 97p.
25. Buckberg GD, Rosenkranz ER. Principles of cardioplegic myocardial protection. In: Roberts AJ, editor. Myocardial protection in cardiac surgery. New York:Marcel Dekker Inc.;1987. p.71-94.
26. Deten A, Marx G, Briest W, Christian Volz H, Zimmer HG. Heart function and molecular biological parameters are comparable in young adult and aged rats after chronic myocardial infarction. Cardiovasc Res. 2005;66(2):364-73.
27. Formigli L, Ibba Manneschi L, Tani A, Gandini E, Adembri C, Pratesi C, et al. Vitamin E prevents neutrophil accumulation and attenuates tissue damage ischemic-reperfused human skeletal muscle. Histol Histopathol. 1997;12(3):663-9.
28. Braile DM, Ardito RV, Zaiantchick M, Santos JLV, Soares MJF. Cardioplegia sangüínea contínua normotérmica. Rev Bras Cir Cardiovasc. 1989;4(2):109-38.